FBIO

Fortress Biotech, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-31

Figures on this page computed 2026-11-08 12:40 UTC

Last close

1.97USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
10.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.37 against 0.52 on the market's range.

Five bars, one line

lens 7 of 9

1.28x

-0.13x

n/a

0.89x

0.08x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Sales1.28x
Its own average over 10 years, 49.3M.
Profit-0.13x
Its own average over 10 years, -54.4M.
Free cash flown/a
Its own average over 9 years, -103.9M.
Debt0.89x
Its own average over 10 years, 77.7M.
Price0.08x
Its own average over 11 years, 26. Market data, 2026-11-04

Profit is furthest from its own average, at -0.13 times.

Sales is 1.28 times its own 10-year average; Profit is -0.13 times its own 10-year average; Debt is 0.89 times its own 10-year average; Price is 0.08 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Sales against its own 10-year average1.28
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Profit against its own 10-year average-0.13
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Free cash flow against its own 9-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Debt against its own 10-year average0.89
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Price against its own 11-year average0.08Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD